C. Foresta et al., ERYTHROPOIETIN AND TESTICULAR STEROIDOGENESIS - THE ROLE OF 2ND-MESSENGERS, European journal of endocrinology, 132(1), 1995, pp. 103-108
It has been demonstrated that erythropoietin (EPO) influences rat and
human Leydig cell steroidogenesis, stimulating testosterone production
through a direct and specific receptor-mediated mechanism. The aim of
this study was to investigate the mechanism by which recombinant huma
n erythropoietin (rHuEPO) exerts its stimulatory effect on rat Leydig
cells. Recombinant human EPO did not induce, at any dose tested (10(-1
0) to 10(-13) mol/l), an increase in either cAMP or cGMP, suggesting t
hat in Leydig cells the effect of rHuEPO does not involve the adenylat
e or guanylate-cyclase systems. The role of transmembrane calcium flux
in rHuEPO-stimulated steroidogenesis was studied by evaluating the ef
fect of calcium channel blocker, verapamil, and by the Ca-45(2+) uptak
e method. Verapamil did not influence rHuEPO-induced testosterone secr
etion and rHuEPO did not modify calcium recycling, indicating that cal
cium transmembrane flux is not involved in the rHuEPO effect. The prot
ein kinase C inhibitor staurosporine (10, 30, 100 and 300 nmol/l) inhi
bited rHuEPO-stimulated testicular steroidogenesis in a dose-dependent
manner. This indirect evidence suggests that the stimulatory effect o
f rHuEPO on rat Leydig cells may involve protein kinase C activation.